Pharmafile Logo
Pharmafocus logo
Advanced Search

Hospira

Showing 15 posts of 31 posts found.

Hospira image

Hospira woes continue as GSK sues over quality failures

March 5, 2013
Manufacturing and Production GSK, Hospira

The difficulties besetting generic firm and contract manufacturer Hospira have taken a new turn with the news that one of …

News
Hospira image

Hospira downgraded as it recalls more sterile injectables

December 18, 2012
Manufacturing and Production FDA, Hospira

Generic pharma company Hospira’s efforts to bring its manufacturing network back into compliance took a knock this week when it …

News
Hospira image

Hospira on track to return propofol to market

November 13, 2012
Manufacturing and Production Ball, Hospira, Teva

Shortages of the short-acting anaesthetic propofol in the US could be helped by the return to market of a generic …

News

Hospira buys Indian antibiotic plant

September 6, 2012
Manufacturing and Production Hospira, India

US injectable drugs specialist Hospira has announced plans to expand in India via the purchase of a manufacturing facility and …

News

Hospira hit by yet another product recall

August 20, 2012
Manufacturing and Production, Sales and Marketing Carpuject, Hospira, overdose, recall

Generic pharma company Hospira has been forced to recall another product as it works to rectify quality issues at three …

News
Michael Ball

Supplier defect blamed in Hospira recall case

July 24, 2012
Manufacturing and Production FDA, Hospira, Michael Ball

Hospira has concluded that a supplier defect was the root cause of its recall of four cancer drugs in the …

News

Pharma manufacturing news in brief

May 29, 2012
Manufacturing and Production Adienne Pharma & Biotech, Hospira, Neuroptis Biotech, Provence Technologies, Selexis and Florida Biologix, baxter

Hospira overfilled Carpuject cartridges, high-potency certification at Baxter, plus updates from Provence Technologies, Selexis and Florida Biologix. 

News

Hospira appoints Richard Davies as chief commercial officer

February 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hospira, Richard Davies

Hospira has announced Richard Davies as its senior vice president and chief commercial officer. In this role, he will be responsible for …

Appointment

Hospira faces lawsuits from disgruntled investors

January 9, 2012
Manufacturing and Production Hospira, generics, manufacturing

Angry investors in US generic drugmaker Hospira have filed a class action lawsuit against the company, alleging that it misled …

News

Pharma manufacturing news in brief

December 6, 2011
Manufacturing and Production GSK, Hospira, PharmaS, UPS, Uquifa, Vivimed

India’s Vivimed buys Spanish API maker, Hospira tries to spend its way out of manufacturing woes, plus updates from PharmaS, …

News

Svend Andersen to lead Hospira in Europe

October 5, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Hospira, appointment, manufacturing and production, research and development, sales and marketing

US global specialty pharmaceutical company Hospira has appointed Svend Andersen to lead its operations in Europe with effect from 1 …

Appointment

Manufacturing news in brief

June 8, 2010
Manufacturing and Production AHP Manufacturing, Caraco Pharmaceutical, Hospira, KV Pharmaceutical, Pharmalucence

The pharmaceutical manufacturing sector had another week of mixed fortunes, with yet more recalls being announced and a former Wyeth …

News

FDA to assess Neupogen biosimilar

February 3, 2010
Research and Development, Sales and Marketing Hospira, Teva, biosimilars

US regulator the FDA has agreed to assess Teva’s application for a biosimilar version of Amgen’s Neupogen (filgrastim). XM02, a …

News

Hospira helps Genzyme tackle manufacturing problems

January 6, 2010
Manufacturing and Production Cerezyme, Fabrazyme, Genzyme, Hospira

Genzyme has taken the decision to move the fill and finish stages of its manufacturing process to Hospira in order …

News
Chris Begley

Hospira buys Orchid generic injectables business for $400m

December 18, 2009
Manufacturing and Production Hospira, India, Orchid, injectables

Indian active pharmaceutical ingredient manufacturer Orchid Chemicals & Pharmaceuticals has signed a $400 million deal to sell the assets of …

News

Latest content

Sanofi shares results from phase 2 trial for frexalimab in MS treatment

July 1, 2024

EMA accepts AstraZeneca’s regulatory submission for sipavibart for COVID-19 prevention

July 1, 2024

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024